Development

Editor of Pharmaceutical Technology Europe

Articles

Putting the patient at the forefront of drug development is essential, particularly to ensure medication compliance is optimized.

Focusing on the Patient in Drug Development

The inaugural Connect in Pharma event will take place on 14 and 15 September in Geneva, Switzerland.

Connecting the Dots for Pharma

Feliza Mirasol is the science editor for 

Videos

In this episode of Drug Digest, Pharmaceutical Technology editors, Felicity Thomas and Feliza Mirasol, examine the topic of emerging therapies in more detail, covering subjects such as the challenges of scale, the potential benefits of drug delivery innovation, importance of early analytical studies, the evolution of the regulatory landscape, and differences between regional regulatory requirements.

Drug Digest: Emerging Therapies in All Shapes and Sizes

Advances in therapeutic modalities and an increase in molecular complexity have led to the need for an evolution in drug delivery approaches over the years.

An Evolving Approach to Drug Delivery 

Lonza has joined IPAC-RS, providing benefits to Lonza’s inhalation- related businesses due to IPAC-RS’ global voice of the orally inhaled and nasal drug products industry.

Lonza Joins IPAC-RS, an International Consortium Advancing the Regulatory Science of Inhalation Products

Sanofi is collaborating with Blackstone Life Sciences to accelerate the development of a treatment for multiple myeloma.

Sanofi Announces €300 million Collaboration with Blackstone Life Sciences to Advance a Treatment for Multiple Myeloma

TFF Pharmaceuticals and Catalent will collaborate to develop TFF's platform for manufacturing dry powder particles. 

TFF Pharmaceuticals and Catalent Announce Development and Manufacturing Agreement

Developers need to consider key challenges when approaching accelerated formulation strategies to ensure success.

Successfully Accelerating Formulation Strategies

Stevanato Group has extended its licensing agreement with Haselmeier for its Axis-D pen injector technology.

Stevanato Group, Haselmeier Extend Licensing Agreement for Pen Injector Technology

Cheryl Barton is director of PharmaVision, 

DTx manufacturers are taking advantage of the new regulatory flexibility, afforded by the COVID-19 pandemic, to pilot new products and generate real-world evidence to support regulatory filing and reimbursement.